Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Deficit) (Tables)

v3.25.0.1
Stockholders’ Equity (Deficit) (Tables)
3 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Warrants Outstanding

As of December 31, 2024, the following equity-classified warrants and related terms were outstanding:

 

    Warrants Outstanding     Exercise Price     Expiration Date  
Common stock warrants August 2021     14,031     $ 2,094.4000       August 24, 2026  
Underwriter warrants August 2021     284     $ 2,618.0000       August 19, 2026  
Chanticleer warrants     6       $144,144.0000 - $224,224.0000       April 30, 2027 - December 17, 2028  
Series C warrants     2,297     $ 7,860.1600       October 16, 2025  
Series 3 warrants     1,566     $ 717.0240       August 15, 2027  
Common stock warrants February 2023     31,563     $ 190.0800       February 10, 2028  
Underwriter warrants February 2023     1,933     $ 237.6000       February 8, 2028  
Common stock private placement warrants June 2023     28,409     $ 12.4000       June 21, 2029  
Placement agent warrants June 2023     852     $ 118.7824       December 30, 2026  
Common stock warrants October 2023     354,994     $ 9.6000       October 27, 2028  
Pre-funded warrants October 2023     99,687     $ 0.0008        
Underwriter warrants October 2023     10,664     $ 16.0000       October 24, 2028  
Placement agent warrants June 2024     14,142     $ 14.8800       June 19, 2029  
Common stock warrants June 2024     703,125     $ 12.4000       June 21, 2029  
Common stock warrants November 2024     2,222,222     $ 4.5000       November 7, 2029  
Common stock registered direct warrants December 2024     1,085,325     $ 2.1000       December 9, 2029  
Common stock PIPE warrants December 2024     673,000     $ 2.1000       December 9, 2029  
Pre-funded warrants December 2024     545,500     $ 0.0001        
Total     5,789,600